Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

RPRX Royalty Pharma PLC

27,22

-0,26 (-0,95%)

Nach Börsenschluss

Zuletzt aktualisiert: 01:43:57

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Royalty Pharma Charts.

Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Royalty Pharma Charts.

News Royalty Pharma PLC

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 16 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

Royalty Pharma to Present at Upcoming Investor Conferences
Montag 13 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Royalty Pharma Reports First Quarter 2024 Results
Donnerstag 9 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
Donnerstag 9 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Freitag 19 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Royalty Pharma Declares Second Quarter 2024 Dividend
Mittwoch 17 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Mittwoch 28 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Royalty Pharma Reports Q4 and Full Year 2023 Results
Donnerstag 15 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Royalty Pharma PLC News-Artikel

Silver Bullet Data Servi...

Glaxe [Project Galaxy]

FinTech Evolution Acquis...

Akropolis Delphi

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen